Sylvia Hafkemeyer

Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis

Anna‐Maria Dittrich, Sarah Sieber, Lutz Naehrlich et al. · International Journal of Infectious Diseases · 2023 · 45 citations · Full text

Medicine, Infectious Diseases, Medical Microbiology +16

Standards for the care of people with cystic fibrosis (CF); Planning for a longer life

Andrea Gramegna, C. Addy, Lorna Allen et al. · Journal of Cystic Fibrosis · 2024 · 32 citations · Full text

Law, Health Policy, End-of-life Care +10

Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients

Nils Wetzstein, Margo Diricks, Thomas A. Kohl et al. · Microbiology Spectrum · 2022 · 24 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

CFTR: New insights into structure and function and implications for modulation by small molecules

Bertrand Kleizen, J.F. Hunt, Isabelle Callebaut et al. · Journal of Cystic Fibrosis · 2019 · 20 citations · Full text

Life Sciences, Biophysics, Molecular Biology +14

Risk factors for cystic fibrosis arthropathy: Data from the German cystic fibrosis registry

Claudia Grehn, Anna‐Maria Dittrich, J. Wosniok et al. · Journal of Cystic Fibrosis · 2021 · 11 citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +15